Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma

被引:40
作者
Bologna-Molina, Ronell [1 ,2 ]
Mosqueda-Taylor, Adalberto [3 ]
Lopez-Corella, Eduardo [4 ]
de Almeida, Oslei Paes [5 ]
Carrasco-Daza, Daniel [4 ]
Farfan-Morales, Jose E. [4 ]
Molina-Frechero, Nelly [3 ]
Damian-Matsumura, Pablo [6 ]
机构
[1] Univ Autonoma Metropolitana, Dept Biol & Hlth Sci, Guadalajara, Jalisco, Mexico
[2] Univ Guadalajara, Hlth Sci Univ Ctr, Guadalajara 44430, Jalisco, Mexico
[3] Univ Autonoma Metropolitana Xochimilco, Hlth Care Dept, Piracicaba, SP, Brazil
[4] Inst Nacl Pediat, Lab Mol Pathol, Piracicaba, SP, Brazil
[5] Univ Estadual Campinas, Sch Dent Piracicaba, Oral Pathol Sect, Dept Oral Diag, Piracicaba, SP, Brazil
[6] Univ Autonoma Metropolitana Iztapalapa, Dept Reprod Biol, Mexico City, DF, Mexico
关键词
ameloblastic carcinoma; CD138; desmoplastic ameloblastoma; Ki-67; peripheral ameloblastoma; syndecan-1; CELL-SURFACE PROTEOGLYCAN; EPITHELIAL-MESENCHYMAL INTERACTIONS; HEPARAN-SULFATE PROTEOGLYCAN; EMBRYONIC TOOTH MESENCHYME; PROGNOSTIC-SIGNIFICANCE; GROWTH-FACTOR; TENASCIN; RECEPTOR; CANCER;
D O I
10.1111/j.1440-1827.2009.02355.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan-1 and Ki-67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan-1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (P < 0.05). Syndecan-1 expression correlated inversely with Ki-67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P < 0.05). The present results suggest that the decrease in syndecan-1 expression and increase in the Ki-67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan-1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 36 条
[21]   Peripheral ameloblastoma: biological profile based on 160 cases from the literature [J].
Philipsen, HP ;
Reichart, PA ;
Nikai, H ;
Takata, T ;
Kudo, Y .
ORAL ONCOLOGY, 2001, 37 (01) :17-27
[22]   Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue [J].
Ro, Y ;
Muramatsu, T ;
Shima, K ;
Yajima, Y ;
Shibahara, T ;
Noma, H ;
Shimono, M .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2006, 35 (03) :252-257
[23]  
RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369
[24]   A NOVEL LAMININ-BINDING FORM OF SYNDECAN-1 (CELL-SURFACE PROTEOGLYCAN) PRODUCED BY SYNDECAN-1 CDNA-TRANSFECTED NIH-3T3 CELLS [J].
SALMIVIRTA, M ;
MALI, M ;
HEINO, J ;
HERMONEN, J ;
JALKANEN, M .
EXPERIMENTAL CELL RESEARCH, 1994, 215 (01) :180-188
[25]  
SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733
[26]   NEURITE GROWTH-PROMOTING PROTEIN (AMPHOTERIN, P-30) BINDS SYNDECAN [J].
SALMIVIRTA, M ;
RAUVALA, H ;
ELENIUS, K ;
JALKANEN, M .
EXPERIMENTAL CELL RESEARCH, 1992, 200 (02) :444-451
[27]  
Sanderson R. D., 1992, J INVEST DERMATOL, V66, P314
[28]   CELL-SURFACE PROTEOGLYCAN BINDS MOUSE MAMMARY EPITHELIAL-CELLS TO FIBRONECTIN AND BEHAVES AS A RECEPTOR FOR INTERSTITIAL MATRIX [J].
SAUNDERS, S ;
BERNFIELD, M .
JOURNAL OF CELL BIOLOGY, 1988, 106 (02) :423-430
[29]   Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma [J].
Shah, L ;
Walter, KL ;
Borczuk, AC ;
Kawut, SM ;
Sonett, JR ;
Gorenstein, LA ;
Ginsburg, ME ;
Steinglass, KM ;
Powell, CA .
CANCER, 2004, 101 (07) :1632-1638
[30]  
Sivapathasundharam B, 2007, Indian J Dent Res, V18, P218